Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;92(7):797-806.
doi: 10.1002/jmv.25783. Epub 2020 Apr 1.

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Suxin Wan  1 , Yi Xiang  1   2 , Wei Fang  1 , Yu Zheng  3 , Boqun Li  1 , Yanjun Hu  1 , Chunhui Lang  1   4 , Daoqiu Huang  1 , Qiuyan Sun  1 , Yan Xiong  1   5 , Xia Huang  1   6 , Jinglong Lv  1   7 , Yaling Luo  8 , Li Shen  1 , Haoran Yang  1 , Gu Huang  1 , Ruishan Yang  1
Affiliations

Clinical features and treatment of COVID-19 patients in northeast Chongqing

Suxin Wan et al. J Med Virol. 2020 Jul.

Abstract

The outbreak of the novel coronavirus in China (SARS-CoV-2) that began in December 2019 presents a significant and urgent threat to global health. This study was conducted to provide the international community with a deeper understanding of this new infectious disease. Epidemiological, clinical features, laboratory findings, radiological characteristics, treatment, and clinical outcomes of 135 patients in northeast Chongqing were collected and analyzed in this study. A total of 135 hospitalized patients with COVID-19 were enrolled. The median age was 47 years (interquartile range, 36-55), and there was no significant gender difference (53.3% men). The majority of patients had contact with people from the Wuhan area. Forty-three (31.9%) patients had underlying disease, primarily hypertension (13 [9.6%]), diabetes (12 [8.9%]), cardiovascular disease (7 [5.2%]), and malignancy (4 [3.0%]). Common symptoms included fever (120 [88.9%]), cough (102 [76.5%]), and fatigue (44 [32.5%]). Chest computed tomography scans showed bilateral patchy shadows or ground glass opacity in the lungs of all the patients. All patients received antiviral therapy (135 [100%]) (Kaletra and interferon were both used), antibacterial therapy (59 [43.7%]), and corticosteroids (36 [26.7%]). In addition, many patients received traditional Chinese medicine (TCM) (124 [91.8%]). It is suggested that patients should receive Kaletra early and should be treated by a combination of Western and Chinese medicines. Compared to the mild cases, the severe ones had lower lymphocyte counts and higher plasma levels of Pt, APTT, d-dimer, lactate dehydrogenase, PCT, ALB, C-reactive protein, and aspartate aminotransferase. This study demonstrates the clinic features and therapies of 135 COVID-19 patients. Kaletra and TCM played an important role in the treatment of the viral pneumonia. Further studies are required to explore the role of Kaletra and TCM in the treatment of COVID-19.

Keywords: COVID-19; clinical features; cognition; northeast Chongqing; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

Figure 1
Figure 1
The epidemiology of the included COVID‐19 patients. COVID‐19, coronavirus disease
Figure 2
Figure 2
The character of the chest computed tomography (CT) scan in new coronavirus pneumonia patients. The letter “l” stands for “lung window”, and “m” stands for “mediastinal window”. The CT images were obtained at both lung and mediastinal window settings, showing the multiple patchy ground‐glass density shadows on each leaf of the lungs, without bronchial obstruction and pleural effusion
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497‐506. - PMC - PubMed
    1. World Health Organization . Clinical management of severe acute respiratory infection when novel coronavirus (2019‐nCoV) infection is suspected: interim guidance, 28 January 2020. World Health Organization. 2020.
    1. General Office of the National Health and Family PlanningCommission . Diagnosis and treatment of novel coronavirus pneumonia (trial version 5). Chin J Integr Med. 2020;3.
    1. Wang F, Sun YG, Yin W, et al. Effects of matrine combied with baicalin on mouse pneumonia induced by LPS. Chin Pharmacol Bull. 2018;8:1105‐1109.
    1. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. BioSci Trends. 2020;14(1):64‐68. - PubMed

Publication types

MeSH terms